MedPath

Methylene Blue INJ

Methylene Blue Injection 1%, USP

Approved
Approval ID

83c12d6b-93ac-45ca-94a6-d9149adf7d2f

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Aug 9, 2023

Manufacturers
FDA

Cameron Pharmaceuticals

DUNS: 078371442

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

METHYLENE BLUE ANHYDROUS

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code42494-419
Product Classification
G
Generic Name
METHYLENE BLUE ANHYDROUS
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateAugust 9, 2023
FDA Product Classification

INGREDIENTS (2)

WaterInactive
Code: 059QF0KO0R
Classification: IACT
METHYLENE BLUE ANHYDROUSActive
Quantity: 10 mg in 1 mL
Code: 8NAP7826UB
Classification: ACTIR

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Methylene Blue INJ - FDA Drug Approval Details